Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.130
+0.120 (5.97%)
Oct 29, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $50.7 million as of October 29, 2026. It is the 29,973rd most valuable company in the world and the 4,609th biggest in the United States. Its market cap has decreased by 45.78% in one year.
Market Cap
50.70M
Enterprise Value
-41.43M
1-Year Change
-45.78%
Global Rank
Country Rank
#4,609 United States
Category
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $50.70M, a decrease of -76.36%. That is a compound annual growth rate of -59.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 50.70M | -67.88% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 54.27M |
| Alps Group | 53.41M |
| Connect Biopharma Holdings | 53.00M |
| Gain Therapeutics | 52.81M |
| Xilio Therapeutics | 52.71M |
| Werewolf Therapeutics | 52.49M |
| iBio, Inc. | 52.15M |
| Caribou Biosciences | 49.86M |